[
  {
    "ts": "2025-12-03T04:25:37+00:00",
    "headline": "Zimmer Biomet (ZBH): Assessing Valuation After a Year of Weak Share Price Performance",
    "summary": "Zimmer Biomet Holdings (ZBH) has been drifting lower recently, with the stock down about 10% over the past 3 months and roughly 14% over the past year despite steady revenue and earnings growth. See our latest analysis for Zimmer Biomet Holdings. That slide reflects fading momentum rather than a collapsing business, with the latest $94.14 share price and weak recent share price returns helping explain why the 1 year total shareholder return has drifted noticeably into negative territory. If...",
    "url": "https://finance.yahoo.com/news/zimmer-biomet-zbh-assessing-valuation-042537123.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b254adda-8258-33b7-ba71-759be6a24c56",
      "content": {
        "id": "b254adda-8258-33b7-ba71-759be6a24c56",
        "contentType": "STORY",
        "title": "Zimmer Biomet (ZBH): Assessing Valuation After a Year of Weak Share Price Performance",
        "description": "",
        "summary": "Zimmer Biomet Holdings (ZBH) has been drifting lower recently, with the stock down about 10% over the past 3 months and roughly 14% over the past year despite steady revenue and earnings growth. See our latest analysis for Zimmer Biomet Holdings. That slide reflects fading momentum rather than a collapsing business, with the latest $94.14 share price and weak recent share price returns helping explain why the 1 year total shareholder return has drifted noticeably into negative territory. If...",
        "pubDate": "2025-12-03T04:25:37Z",
        "displayTime": "2025-12-03T04:25:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zimmer-biomet-zbh-assessing-valuation-042537123.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zimmer-biomet-zbh-assessing-valuation-042537123.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZBH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]